How many Sangamo Therapeutics shares are in issue?
Sangamo Therapeutics has 177,347,000 shares in issue.
What is the market cap of Sangamo Therapeutics?
The market capitalisation of Sangamo Therapeutics is USD 2.75 B.
What is the 1 year trading range for Sangamo Therapeutics share price?
Sangamo Therapeutics has traded in the range of US$ 15.50 to US$ 15.50 during the past year.
What is the PE ratio of Sangamo Therapeutics?
The price to earnings ratio of Sangamo Therapeutics is -1.49.
What is the cash to sales ratio of Sangamo Therapeutics?
The cash to sales ratio of Sangamo Therapeutics is 2.17.
What is the reporting currency for Sangamo Therapeutics?
Sangamo Therapeutics reports financial results in USD.
What is the latest annual turnover for Sangamo Therapeutics?
The latest annual turnover of Sangamo Therapeutics is USD 176.23M.
What is the latest annual profit for Sangamo Therapeutics?
The latest annual profit of Sangamo Therapeutics is USD -257.83M.
What is the registered address of Sangamo Therapeutics?
The registered address for Sangamo Therapeutics is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801.
What is the Sangamo Therapeutics website address?
The website address for Sangamo Therapeutics is www.sangamo.com.
Which industry sector does Sangamo Therapeutics operate in?
Sangamo Therapeutics operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector.
Register for streaming realtime charts, analysis tools, and prices.
Hot Features
Premium
